Monash IVF Group Annual Report 2021

A Year in Review

An additional Day
Hospital opened

12.11.20

Sydney CBD

Total domestic
stimulated cycles

36.6%

on FY20 (FY21; 9,808)

New patient
stimulated cycles

40%

Ultrasound
scans

12.9%

on FY20 (FY21; 92,776)

Non-invasive
Pre Natal Testing

17.8%

on FY20 (FY21; 15,877)

Total Group
IVF treatments

32.5%

on FY20 (FY21; 19,733)

Pregnancy
Rates

Improved by

4.5%

since 2018

Engagement –
Culture of Success

61%

NPS
score

+61%

up from 58.5% in 2020

12 New Fertility Specialists

joined Monash IVF Group in FY21 through recruitment, as well as through our internal training program.

Revenue

$183.6m

26.3% on FY20
Adjusted NPAT 1,2,3

$23.3m

 61.5% on FY20

Adjusted EBITDA 1,2

$47.7m

 37.1% on FY20

Adjusted EBIT 1,2

$34.8m

42.6% on FY20

Reported NPAT 3

$25.5m

116.9% on FY20

Reported EBITDA 1

$51.3m

56.2% on FY20

1.  Non-IFRS measure
2. Refer to page 29 for reconciliation of Reported EBITDA, EBIT and NPAT to Adjusted EBITDA, EBIT and NPAT
3. NPAT including minority interest